Estrella Immunopharma Inc.
ESLAW
$0.07+0.14%
At close · Oct 30, 2026
Mkt cap
—
EV/Sales
—
P/E ratio
—
Revenue
—
EPS
—
Gross Margin
—
Profit Margin
—
Beta
−0.09
Div yield
—
Sector
Healthcare
Overview
What matters now, from SEC filings and analyst ratings
Takeaway
A takeaway appears here once the latest filing has been analyzed.
Analysts
RatingsFinancials
Earnings
Ownership
Insiders
Form 4 trades, last 90 days
Filings
Latest SEC filings
- 8-KOct 29, 2026Current report
- 8-KSep 8, 2026Current report
- 8-KAug 21, 2026Current report
- 8-KJun 30, 2026Current report
- 8-KJan 13, 2026Current report
Source: SEC EDGAR · Latest filing Oct 29, 2026
News
Latest stored headlines
ESLAW — Estrella Immunopharma Inc.
ESLAW Key Statistics
- Previous Close: $0.07
- Day Range: $0.07 – $0.11
Estrella Immunopharma Inc. (ESLAW) is a biotechnology company listed on US.
Use this ESLAW research hub for sector, financials, and filings — not a live tape.
ESLAW recent filings
ESLAW FAQ
What industry is ESLAW in?
Estrella Immunopharma Inc. (ESLAW) is a biotechnology company in the Healthcare sector.
What are ESLAW's previous close and day range?
Estrella Immunopharma Inc. (ESLAW) cached previous close $0.07; day range $0.07 – $0.11. Session quote: https://lician.com/quote/eslaw
What is the latest ESLAW SEC filing?
The latest cached ESLAW filing is 8-K · Oct 29, 2026. Filings: https://lician.com/sec/eslaw